Adaptive Biotechnologies (ADPT) Moves to Buy: Rationale Behind the Upgrade
Adaptive Biotechnologies (ADPT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the companys earnings prospects.…
7,147$
-3,54%
Echtzeit-Aktienkurs Adaptive Biotechnologies Corp.
Bid:
Ask:
Nachrichten zur Adaptive Biotechnologies Corp. Aktie
Are Medical Stocks Lagging Adaptive Biotechnologies (ADPT) This Year?
Here is how Adaptive Biotechnologies (ADPT) and Castle Biosciences, Inc. (CSTL) have performed compared to their sector so far this…
Adaptive Biotechnologies (ADPT) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Adaptive Biotechnologies (ADPT) give insight into how the company performed in the quarter ended December 2024,…
Adaptive Biotechnologies (ADPT) Reports Q4 Loss, Tops Revenue Estimates
Adaptive Biotechnologies (ADPT) delivered earnings and revenue surprises of 11.54% and 2.23%, respectively, for the quarter ended December 2024. Do…